{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:58:15Z","timestamp":1792839495075,"version":"4.5.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T00:00:00Z","timestamp":1190764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2007,11,8]]},"DOI":"10.1007\/s12016-007-8003-8","type":"journal-article","created":{"date-parts":[[2007,9,25]],"date-time":"2007-09-25T10:57:27Z","timestamp":1190717847000},"page":"238-251","source":"Crossref","is-referenced-by-count":100,"title":["Sj\u00f6gren\u2019s Syndrome\u2014Study of Autoantigens and Autoantibodies"],"prefix":"10.1007","volume":"32","author":[{"given":"John G.","family":"Routsias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,26]]},"reference":[{"key":"8003_CR1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Tala N, Weisman MH (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"8003_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/10408360500523837","volume":"43","author":"JG Routsias","year":"2006","unstructured":"Routsias JG, Vlachoyiannopoulos PG, Tzioufas AG (2006) Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci 43:203\u2013248","journal-title":"Crit Rev Clin Lab Sci"},{"key":"8003_CR3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2177\/jsci.26.346","volume":"26","author":"K Iwasaki","year":"2003","unstructured":"Iwasaki K, Okawa-Takatsuji M, Aotsuka S, Ono T (2003) Detection of anti-SS-A\/Ro and anti-SS-B\/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sjogren\u2019s syndrome. Nihon Rinsho Meneki Gakkai Kaishi 26:346\u2013354","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"8003_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0714.2004.00301.x","volume":"34","author":"AR Hammi","year":"2005","unstructured":"Hammi AR, Al-Hashimi IH, Nunn ME, Zipp M (2005) Assessment of SS-A and SS-B in parotid saliva of patients with Sjogren\u2019s syndrome. J Oral Pathol Med 34:198\u2013203","journal-title":"J Oral Pathol Med"},{"key":"8003_CR5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.1999.00778.x","volume":"115","author":"A Halse","year":"1999","unstructured":"Halse A, Harley JB, Kroneld U, Jonsson R (1999) Ro\/SS-A reative B lymphocytes in salivary glands and peripheral blood of patients with Sjogren\u2019s syndrome. Clin Exp Immunol 115:203\u2013207","journal-title":"Clin Exp Immunol"},{"key":"8003_CR6","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.11311","volume":"48","author":"S Salomonsson","year":"2003","unstructured":"Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, Jonsson R (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patiens with Sjogren\u2019s syndrome. Arthritis Rheum 48:3187\u20133201","journal-title":"Arthritis Rheum"},{"key":"8003_CR7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-3083.2002.01058.x","volume":"55","author":"S Salomonsson","year":"2002","unstructured":"Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M (2002) Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren\u2019s syndrome. Scand J Immunol 55:336\u2013342","journal-title":"Scand J Immunol"},{"key":"8003_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/jaut.1999.0333","volume":"13","author":"AG Tzioufas","year":"1999","unstructured":"Tzioufas AG, Hantoumi I, Polihronis M, Xanthou G, Moutsopoulos HM (1999) Autoantibodies to La\/SSB in patients with primary Sjogren\u2019s syndrome (pSS) are associated with upregulation of La\/SSB mRNA in minor salivary gland biopsies (MSGs). J Autoimmun 13:429\u2013434","journal-title":"J Autoimmun"},{"key":"8003_CR9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00918149","volume":"12","author":"DI Yannopoulos","year":"1992","unstructured":"Yannopoulos DI, Roncin S, Lamour A, Pennec YL, Moutsopoulos HM, Youinou P (1992) Conjunctival epithelial cells from patients with Sjogren\u2019s syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins. J Clin Immunol 12:259\u2013265","journal-title":"J Clin Immunol"},{"key":"8003_CR10","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/art.21005","volume":"52","author":"EK Kapsogeorgou","year":"2005","unstructured":"Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2005) Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 52:1517\u20131521","journal-title":"Arthritis Rheum"},{"key":"8003_CR11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","volume":"167","author":"E Ben-Chetrit","year":"1988","unstructured":"Ben-Chetrit E, Chan EK, Sullivan KF, Tan EM (1988) A 52-kD protein is a novel component of the SS-A\/Ro antigenic particle. J Exp Med 167:1560\u20131571","journal-title":"J Exp Med"},{"key":"8003_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0022-2836(92)90890-V","volume":"227","author":"RL Slobbe","year":"1992","unstructured":"Slobbe RL, Pluk W, van Venrooij WJ, Pruijn GJ (1992) Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions. J Mol Biol 227:361\u2013366","journal-title":"J Mol Biol"},{"key":"8003_CR13","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.156.11.4484","volume":"156","author":"ST Cheng","year":"1996","unstructured":"Cheng ST, Nguyen TQ, Yang YS, Capra JD, Sontheimer RD (1996) Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro\/SS-A ribonucleoprotein autoantigen. J Immunol 156:4484\u20134491","journal-title":"J Immunol"},{"key":"8003_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-2836(02)00518-1","volume":"320","author":"MA Fouraux","year":"2002","unstructured":"Fouraux MA, Bouvet P, Verkaart S, van Venrooij WJ, Pruijn GJ (2002) Nucleolin associates with a subset of the human Ro ribonucleoprotein complexes. J Mol Biol 320:475\u2013488","journal-title":"J Mol Biol"},{"key":"8003_CR15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1242\/jcs.106.3.929","volume":"106","author":"R Peek","year":"1993","unstructured":"Peek R, Pruijn GJ, van der Kemp AJ, van Venrooij WJ (1993) Subcellular distribution of Ro ribonucleoprotein complexes and their constituents. J Cell Sci 106:929\u2013935","journal-title":"J Cell Sci"},{"key":"8003_CR16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1083\/jcb.125.5.981","volume":"125","author":"FH Simons","year":"1994","unstructured":"Simons FH, Pruijn GJ, van Venrooij WJ (1994) Analysis of the intracellular localization and assembly of Ro ribonucleoprotein particles by microinjection into Xenopus laevis oocytes. J Cell Biol 125:981\u2013988","journal-title":"J Cell Biol"},{"key":"8003_CR17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/nar\/gkg161","volume":"31","author":"SS Krishna","year":"2003","unstructured":"Krishna SS, Majumdar I, Grishin NV (2003) Structural classification of zinc fingers: survey and summary. Nucleic Acids Res 31:532\u2013550","journal-title":"Nucleic Acids Res"},{"key":"8003_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/jmbi.1994.1222","volume":"237","author":"PN Barlow","year":"1994","unstructured":"Barlow PN, Luisi B, Milner A, Elliott M, Everett R (1994) Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J Mol Biol 237:201\u2013211","journal-title":"J Mol Biol"},{"key":"8003_CR19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A (1998) The ubquitin system. Annu Rev Biochem 67:425\u2013479","journal-title":"Annu Rev Biochem"},{"key":"8003_CR20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-5793(93)80741-C","volume":"335","author":"KL Borden","year":"1993","unstructured":"Borden KL, Martin SR, O\u2019Reilly NJ, Lally JM, Reddy BA, Etkin LD, Reemont PS (1993) Characterisation of a novel cysteine\/histidine-rich metal binding domain from Xenopus nuclear factor XNF7. FEBS Lett 335:255\u2013260","journal-title":"FEBS Lett"},{"key":"8003_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-4165(01)00212-4","volume":"1568","author":"D Wang","year":"2001","unstructured":"Wang D, Buyon JP, Yang Z, Di Donato F, Miranda-Carus ME, Chan EK (2001) Leucine zipper domain of 52 kDa SS-A\/Ro promotes protein dimer formation and inhibits in vitro transcription activity. Biochim Biophys Acta 1568:155\u2013161","journal-title":"Biochim Biophys Acta"},{"key":"8003_CR22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1006\/bbrc.1999.0835","volume":"259","author":"MB Frank","year":"1999","unstructured":"Frank MB (1999) Charaterization of DNA binding properties and sequence specificity of the human 52 kDa Ro\/SS-A (Ro52) zinc finger protein. Biochem Biophys Res Commun 259:665\u2013670","journal-title":"Biochem Biophys Res Commun"},{"key":"8003_CR23","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","volume":"176","author":"A Espinosa","year":"2006","unstructured":"Espinosa A, Zhou W, Ek M, Hedlund M, Brauner S, Popovic K, Horvath L, Wallerskog T, Oukka M, Nyberg F, Kuchroo VK, Wahren-Herlenius M (2006) The Sjogren\u2019s syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J Immunol 176:6277\u20136285","journal-title":"J Immunol"},{"key":"8003_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/jaut.1994.1020","volume":"7","author":"I Blange","year":"1994","unstructured":"Blange I, Ringertz NR, Pettersson I (1994) Identification of antigenic regions of the human 52kD Ro\/SS-A protein recognized by patient sera. J Autoimmun 7:263\u2013274","journal-title":"J Autoimmun"},{"key":"8003_CR25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/art.1780380716","volume":"38","author":"T Kato","year":"1995","unstructured":"Kato T, Sasakawa H, Suzuki S, Shirako M, Tashiro F, Nishioka K, Yamamoto K (1995) Autoepitopes of the 52-kd SS-A\/Ro molecule. Arthritis Rheum 38:990\u2013998","journal-title":"Arthritis Rheum"},{"key":"8003_CR26","first-page":"462","volume":"23","author":"T Dorner","year":"1996","unstructured":"Dorner T, Feist E, Wagenmann A, Kato T, Yamamoto K, Nishioka K, Burmester GR, Hiepe F (1996) Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. J Rheumatol 23:462\u2013468","journal-title":"J Rheumatol"},{"key":"8003_CR27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/art.10232","volume":"46","author":"S Salomonsson","year":"2002","unstructured":"Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M (2002) A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 46:1233\u20131241","journal-title":"Arthritis Rheum"},{"key":"8003_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20041859","volume":"201","author":"S Salomonsson","year":"2005","unstructured":"Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thoren P, Herlenius E, Wahren-Herlenius M (2005) Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 201:11\u201317","journal-title":"J Exp Med"},{"key":"8003_CR29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.510240616","volume":"24","author":"T Dorner","year":"1996","unstructured":"Dorner T, Feist E, Held C, Conrad K, Burmester GR, Hiepe F (1996) Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjogren\u2019s syndrome. Hepatology 24:1404\u20131407","journal-title":"Hepatology"},{"key":"8003_CR30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00109-004-0529-0","volume":"82","author":"X Chen","year":"2004","unstructured":"Chen X, Wolin SL (2004) The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity. J Mol Med 82:232\u2013239","journal-title":"J Mol Med"},{"key":"8003_CR31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2005.03.009","volume":"121","author":"AJ Stein","year":"2005","unstructured":"Stein AJ, Fuchs G, Fu C, Wolin SL, Reinisch KM (2005) Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity. Cell 121:529\u2013539","journal-title":"Cell"},{"key":"8003_CR32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1101\/gad.14.7.777","volume":"14","author":"X Chen","year":"2000","unstructured":"Chen X, Quinn AM, Wolin SL (2000) Ro ribonucleoproteins contribute to the resistance of Deincoccus radiodurans to ultraviolet irradiation. Genes Dev 14:777\u2013782","journal-title":"Genes Dev"},{"key":"8003_CR33","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.0832411100","volume":"100","author":"D Xue","year":"2003","unstructured":"Xue D, Shi H, Smith JD, Chen X, Noe DA, Cedervall T, Yang DD, Eynon E, Brash DE, Kashgarian M, Flavell RA, Wolin SL (2003) A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci U S A 100:7503\u20137508","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8003_CR34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF03402110","volume":"6","author":"NM Moutsopoulos","year":"2000","unstructured":"Moutsopoulos NM, Routsias JG, Vlachoyiannopoulos PG, Tzioufas AG, Moutsopoulos HM (2000) B-cell epitopes of intracellular autoantigens: myth and reality. Mol Med 6:141\u2013151","journal-title":"Mol Med"},{"key":"8003_CR35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0167-5699(99)01458-9","volume":"20","author":"M Wahren-Herlenius","year":"1999","unstructured":"Wahren-Herlenius M, Muller S, Isenberg D (1999) Analysis of B-cell epitopes of the Ro\/SS-A autoantigen. Immunol Today 20:234\u2013240","journal-title":"Immunol Today"},{"key":"8003_CR36","first-page":"1073","volume":"21","author":"DP McCauliffe","year":"1994","unstructured":"McCauliffe DP, Yin H, Wang LX, Lucas L (1994) Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins. J Rheumatol 21:1073\u20131080","journal-title":"J Rheumatol"},{"key":"8003_CR37","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.4049\/jimmunol.152.8.4192","volume":"152","author":"MR Saitta","year":"1994","unstructured":"Saitta MR, Arnett FC, Keene JD (1994) 60-kDa Ro protein autoepitopes identified using recombinant polypeptides. J Immunol 152:4192\u20134202","journal-title":"J Immunol"},{"key":"8003_CR38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0896-8411(92)90146-H","volume":"5","author":"M Wahren","year":"1992","unstructured":"Wahren M, Ruden U, Andersson B, Ringertz NR, Pettersson I (1992) Identification of antigenic regions of the human Ro 60 kDa protein using recombinant antigen and synthetic peptides. J Autoimmun 5:319\u2013332","journal-title":"J Autoimmun"},{"key":"8003_CR39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF00918804","volume":"11","author":"RH Scofield","year":"1991","unstructured":"Scofield RH, Dickey WD, Jackson KW, James JA, Harley JB (1991) A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein. J Clin Immunol 11:378\u2013388","journal-title":"J Clin Immunol"},{"key":"8003_CR40","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1073\/pnas.88.8.3343","volume":"88","author":"RH Scofield","year":"1991","unstructured":"Scofield RH, Harley JB (1991) Autoantigenicity of Ro\/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus. Proc Natl Acad Sci USA 88:3343\u20133347","journal-title":"Proc Natl Acad Sci USA"},{"key":"8003_CR41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-2362.1996.186316.x","volume":"26","author":"JG Routsias","year":"1996","unstructured":"Routsias JG, Tzioufas AG, Sakarellos-Daitsiotis M, Sakarellos C, Moutsopoulos HM (1996) Epitope mapping of the Ro\/SSA60KD autoantigen reveals disease-specific antibody-binding profiles. Eur J Clin Invest 26:514\u2013521","journal-title":"Eur J Clin Invest"},{"key":"8003_CR42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-3083.1998.00301.x","volume":"47","author":"JG Routsias","year":"1998","unstructured":"Routsias JG, Sakarellos-Daitsiotis M, Tsikaris V, Sakarellos C, Moutsopoulos HM, Tzioufas AG (1998) Structural, molecular and immunological properties of linear B-cell epitopes of Ro60KD autoantigen. Scand J Immunol 47:280\u2013287","journal-title":"Scand J Immunol"},{"key":"8003_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","volume":"11","author":"MT McClain","year":"2005","unstructured":"McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85\u201389","journal-title":"Nat Med"},{"key":"8003_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08916930500484849","volume":"39","author":"BD Poole","year":"2006","unstructured":"Poole BD, Scofield RH, Harley JB, James JA (2006) Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39:63\u201370","journal-title":"Autoimmunity"},{"key":"8003_CR45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.2003.02246.x","volume":"134","author":"EV Staikou","year":"2003","unstructured":"Staikou EV, Routsias JG, Makri AA, Terzoglou A, Sakarellos-Daitsiotis M, Sakarellos C, Panayotou G, Moutsopoulos HM, Tzioufas AG (2003) Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies. Clin Exp Immunol 134:143\u2013150","journal-title":"Clin Exp Immunol"},{"key":"8003_CR46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.biochem.71.090501.150003","volume":"71","author":"SL Wolin","year":"2002","unstructured":"Wolin SL, Cedervall T (2002) The La protein. Annu Rev Biochem 71:375\u2013403","journal-title":"Annu Rev Biochem"},{"key":"8003_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.10.011","volume":"340","author":"JG Routsias","year":"2004","unstructured":"Routsias JG, Tzioufas AG, Moutsopoulos HM (2004) The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta 340:1\u201325","journal-title":"Clin Chim Acta"},{"key":"8003_CR48","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0969-2126(03)00121-7","volume":"11","author":"A Jacks","year":"2003","unstructured":"Jacks A, Babon J, Kelly G, Manolaridis I, Cary PD, Curry S, Conte MR (2003) Structure of the C-terminal domain of human La protein reveals a novel RNA recognition motif coupled to a helical nuclear retention element. Structure 11:833\u2013843","journal-title":"Structure"},{"key":"8003_CR49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nsmb747","volume":"11","author":"C Alfano","year":"2004","unstructured":"Alfano C, Sanfelice D, Bbon J, Kelly G, Jacks A, Curry S, Conte MR (2004) Structural analysis of cooperative RNA binding by the La motif and central RRM domain of human La protein. Nat Struct Mol Biol 11:323\u2013329","journal-title":"Nat Struct Mol Biol"},{"key":"8003_CR50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/MCB.21.2.367-379.2001","volume":"21","author":"RJ Maraia","year":"2001","unstructured":"Maraia RJ, Intine RV (2001) Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function. Mol Cell Biol 21:367\u2013379","journal-title":"Mol Cell Biol"},{"key":"8003_CR51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2249.1997.d01-1003.x","volume":"108","author":"AG Tzioufas","year":"1997","unstructured":"Tzioufas AG, Yiannaki E, Sakarellos-Daitsiotis M, Routsias JG, Sakarellos C, Moutsopoulos HM (1997) Fine specificity of autoantibodies to La\/SSB: epitope mapping, and characterization. Clin Exp Immunol 108:191\u2013198","journal-title":"Clin Exp Immunol"},{"key":"8003_CR52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780290207","volume":"29","author":"JB Harley","year":"1986","unstructured":"Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, Yamagata H, Arnett FC (1986) Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren\u2019s syndrome. Arthritis Rheum 29:196\u2013206","journal-title":"Arthritis Rheum"},{"key":"8003_CR53","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/art.20093","volume":"50","author":"MN Manoussakis","year":"2004","unstructured":"Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM (2004) Sjogren\u2019s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren\u2019s syndrome. Arthritis Rheum 50:882\u2013891","journal-title":"Arthritis Rheum"},{"key":"8003_CR54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002281-199609000-00016","volume":"8","author":"JP Buyon","year":"1996","unstructured":"Buyon JP (1996) Neonatal lupus. Curr Opin Rheumatol 8:485\u2013490","journal-title":"Curr Opin Rheumatol"},{"key":"8003_CR55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rdc.2005.01.010","volume":"31","author":"JP Buyon","year":"2005","unstructured":"Buyon JP, Clancy RM (2005) Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin North Am 31:299\u2013313:vii","journal-title":"Rheum Dis Clin North Am"},{"key":"8003_CR56","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/art.21954","volume":"54","author":"EA Stea","year":"2006","unstructured":"Stea EA, Routsias JG, Clancy RM, Buyon JP, Moutsopoulos HM, Tzioufas AG (2006) Anti-La\/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum 54:2228\u20132234","journal-title":"Arthritis Rheum"},{"key":"8003_CR57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/32.4.297","volume":"32","author":"PG Vlachoyiannopoulos","year":"1993","unstructured":"Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM (1993) Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 32:297\u2013301","journal-title":"Br J Rheumatol"},{"key":"8003_CR58","first-page":"785","volume":"64","author":"P Caramaschi","year":"1997","unstructured":"Caramaschi P, Biasi D, Carletto A, Manzo T, Randon M, Zeminian S, Bambara LM (1997) Sjogren\u2019s syndrome with anticentromere antibodies. Rev Rhum Engl Ed 64:785\u2013788","journal-title":"Rev Rhum Engl Ed"},{"key":"8003_CR59","first-page":"1121","volume":"31","author":"SR Pillemer","year":"2004","unstructured":"Pillemer SR, Casciola-Rosen L, Baum BJ, Rosen A, Gelber AC (2004) Centromere protein C is a target of autoantibodies in Sjogren\u2019s syndrome and is uniformly associated with antibodies to Ro and La. J Rheumatol 31:1121\u20131125","journal-title":"J Rheumatol"},{"key":"8003_CR60","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00296-004-0568-4","volume":"26","author":"TC Hsu","year":"2006","unstructured":"Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, Tsay GJ (2006) Anti-CENP-H antibodies in patients with Sjogren\u2019s syndrome. Rheumatol Int 26:298\u2013303","journal-title":"Rheumatol Int"},{"key":"8003_CR61","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/gast.1996.v110.pm8613065","volume":"110","author":"J Kino-Ohsaki","year":"1996","unstructured":"Kino-Ohsaki J, Nishimori I, Morita M, Okazaki K, Yamamoto Y, Onishi S, Hollingsworth MA (1996) Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren\u2019s syndrome. Gastroenterology 110:1579\u20131586","journal-title":"Gastroenterology"},{"key":"8003_CR62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.1780350112","volume":"35","author":"Y Itoh","year":"1992","unstructured":"Itoh Y, Reichlin M (1992) Antibodies to carbonic anhydrase in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 35:73\u201382","journal-title":"Arthritis Rheum"},{"key":"8003_CR63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0923-1811(91)90060-B","volume":"2","author":"Y Inagaki","year":"1991","unstructured":"Inagaki Y, Jinno-Yoshida Y, Hamasaki Y, Ueki H (1991) A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjogren\u2019s syndrome. J Dermatol Sci 2:147\u2013154","journal-title":"J Dermatol Sci"},{"key":"8003_CR64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","volume":"47","author":"TH Maren","year":"1967","unstructured":"Maren TH (1967) Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 47:595\u2013781","journal-title":"Physiol Rev"},{"key":"8003_CR65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.1980.20","volume":"17","author":"G Lonnerholm","year":"1980","unstructured":"Lonnerholm G, Ridderstrale Y (1980) Intracellular distribution of carbonic anhydrase in the rat kidney. Kidney Int 17:162\u2013174","journal-title":"Kidney Int"},{"key":"8003_CR66","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.154.9.4865","volume":"154","author":"I Nishimori","year":"1995","unstructured":"Nishimori I, Bratanova T, Toshkov I, Caffrey T, Mogaki M, Shibata Y, Hollingsworth MA (1995) Induction of experimental autoimmune sialoadenitis by immunization of PL\/J mice with carbonic anhydrase II. J Immunol 154:4865\u20134873","journal-title":"J Immunol"},{"key":"8003_CR67","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2004.07.049","volume":"118","author":"F Takemoto","year":"2005","unstructured":"Takemoto F, Hoshino J, Sawa N, Tamura Y, Tagami T, Yokota M, Katori H, Yokoyama K, Ubara Y, Hara S, Takaichi K, Yamada A, Uchida S (2005) Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome. Am J Med 118:181\u2013184","journal-title":"Am J Med"},{"key":"8003_CR68","first-page":"323","volume":"37","author":"NJ Birdsall","year":"1983","unstructured":"Birdsall NJ, Hulme EC, Stockton J, Burgen AS, Berrie CP, Hammer R, Wong EH, Zigmond MJ (1983) Muscarinic receptor subclasses: evidence from binding studies. Adv Biochem Psychopharmacol 37:323\u2013329","journal-title":"Adv Biochem Psychopharmacol"},{"key":"8003_CR69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.3037705","volume":"237","author":"TI Bonner","year":"1987","unstructured":"Bonner TI, Buckley NJ, Young AC, Brann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527\u2013532","journal-title":"Science"},{"key":"8003_CR70","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/j.1460-2075.1987.tb02733.x","volume":"6","author":"EG Peralta","year":"1987","unstructured":"Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ (1987) Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 6:3923\u20133929","journal-title":"EMBO J"},{"key":"8003_CR71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0031-6997(24)01362-0","volume":"50","author":"MP Caulfield","year":"1998","unstructured":"Caulfield MP, Birdsall NJ (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279\u2013290","journal-title":"Pharmacol Rev"},{"key":"8003_CR72","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0024-3205(97)00433-5","volume":"61","author":"FJ Ehlert","year":"1997","unstructured":"Ehlert FJ, Ostrom RS, Sawyer GW (1997) Subtypes of the muscarinic receptor in smooth muscle. Life Sci 61:1729\u20131740","journal-title":"Life Sci"},{"key":"8003_CR73","doi-asserted-by":"crossref","first-page":"C1063","DOI":"10.1152\/ajpcell.1991.261.6.C1063","volume":"261","author":"YS Dai","year":"1991","unstructured":"Dai YS, Ambudkar IS, Horn VJ, Yeh CK, Kousvelari EE, Wall SJ, Li M, Yasuda RP, Wolfe BB, Baum BJ (1991) Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am J Physiol 261:C1063\u2013C1073","journal-title":"Am J Physiol"},{"key":"8003_CR74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1113\/jphysiol.2004.064626","volume":"558","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Matsui M, Uchida K, Futatsugi A, Kusakawa S, Matsumoto N, Nakamura K, Manabe T, Taketo MM, Mikoshiba K (2004) M(3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. J Physiol 558:561\u2013575","journal-title":"J Physiol"},{"key":"8003_CR75","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/labinvest.3700173","volume":"84","author":"J Li","year":"2004","unstructured":"Li J, Ha YM, Ku NY, Choi SY, Lee SJ, Oh SB, Kim JS, Lee JH, Lee EB, Song YW, Park K (2004) Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren\u2019s syndrome. Lab Invest 84:1430\u20131438","journal-title":"Lab Invest"},{"key":"8003_CR76","first-page":"151","volume":"39","author":"S Bacman","year":"1998","unstructured":"Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren\u2019s syndrome. Invest Ophthalmol Vis Sci 39:151\u2013156","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8003_CR77","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","volume":"95","author":"CP Robinson","year":"1998","unstructured":"Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA, Peen E, Jonsson R, Humphreys-Beher MG (1998) Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren\u2019s syndrome. Proc Natl Acad Sci U S A 95:7538\u20137543","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8003_CR78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0300-9475.2004.01395.x","volume":"59","author":"D Cavill","year":"2004","unstructured":"Cavill D, Waterman SA, Gordon TP (2004) Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren\u2019s syndrome. Scand J Immunol 59:261\u2013266","journal-title":"Scand J Immunol"},{"key":"8003_CR79","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1002\/art.20625","volume":"50","author":"F Wang","year":"2004","unstructured":"Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP (2004) Passive transfer of Sjogren\u2019s syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 50:3637\u20133645","journal-title":"Arthritis Rheum"},{"key":"8003_CR80","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1002\/art.11343","volume":"48","author":"D Cavill","year":"2003","unstructured":"Cavill D, Waterman SA, Gordon TP (2003) Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission. Arthritis Rheum 48:3597\u20133602","journal-title":"Arthritis Rheum"},{"key":"8003_CR81","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1076\/ceyr.17.12.1135.5124","volume":"17","author":"SR Bacman","year":"1998","unstructured":"Bacman SR, Berra A, Sterin-Borda L, Borda ES (1998) Human primary Sjogren\u2019s syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 17:1135\u20131142","journal-title":"Curr Eye Res"},{"key":"8003_CR82","first-page":"321","volume":"42","author":"S Bacman","year":"2001","unstructured":"Bacman S, Berra A, Sterin-Borda L, Borda E (2001) Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Invest Ophthalmol Vis Sci 42:321\u2013327","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8003_CR83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/clim.2002.5228","volume":"104","author":"A Berra","year":"2002","unstructured":"Berra A, Sterin-Borda L, Bacman S, Borda E (2002) Role of salivary IgA in the pathogenesis of Sjogren syndrome. Clin Immunol 104:49\u201357","journal-title":"Clin Immunol"},{"key":"8003_CR84","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/rheumatology\/keh389","volume":"43","author":"LJ Dawson","year":"2004","unstructured":"Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM (2004) Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren\u2019s syndrome using conventional immunological approaches. Rheumatology (Oxford) 43:1488\u20131495","journal-title":"Rheumatology (Oxford)"},{"key":"8003_CR85","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/art.20371","volume":"50","author":"J Gao","year":"2004","unstructured":"Gao J, Cha S, Jonsson R, Opalko J, Peck AB (2004) Detection of antitype 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren\u2019s syndrome patients by use of a transfected cell line assay. Athritis Rheum 50:2615\u20132621","journal-title":"Athritis Rheum"},{"key":"8003_CR86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2004.11.005","volume":"24","author":"I Marczinovits","year":"2005","unstructured":"Marczinovits I, Kovacs L, Gyorgy A, Toth GK, Dorgai L, Molnar J, Pokorny G (2005) A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren\u2019s syndrome. J Autoimmune 24:47\u201354","journal-title":"J Autoimmune"},{"key":"8003_CR87","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/rheumatology\/keh672","volume":"44","author":"L Kovacs","year":"2005","unstructured":"Kovacs L, Marczinovits I, Gyorgy A, Toth GK, Dorgai L, Pal J, Molnar J, Pokorny G (2005) Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren\u2019s syndrome. Rheumatology (Oxford) 44:1021\u20131025","journal-title":"Rheumatology (Oxford)"},{"key":"8003_CR88","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/1529-0131(200110)44:10<2376::AID-ART402>3.0.CO;2-E","volume":"44","author":"K Nagaraju","year":"2001","unstructured":"Nagaraju K, Cox A, Casciola-Rosen L, Rosen A (2001) Novel fragments of the Sjogren\u2019s syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death. Arthritis Rheum 44:2376\u20132386","journal-title":"Arthritis Rheum"},{"key":"8003_CR89","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/art.21347","volume":"52","author":"L Dawson","year":"2005","unstructured":"Dawson L, Tobin A, Smith P, Gordon T (2005) Antimuscarinic antibodies in Sjogren\u2019s syndrome: where are we, and where are we going? Arthritis Rheum 52:2984\u20132995","journal-title":"Arthritis Rheum"},{"key":"8003_CR90","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","volume":"43","author":"SA Waterman","year":"2000","unstructured":"Waterman SA, Gordon TP, Rischmueller M (2000) Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren\u2019s syndrome. Arthritis Rheum 43:1647\u20131654","journal-title":"Arthritis Rheum"},{"key":"8003_CR91","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","volume":"104","author":"S Bacman","year":"1996","unstructured":"Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E (1996) Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren\u2019s syndrome. Clin Exp Immunol 104:454\u2013459","journal-title":"Clin Exp Immunol"},{"key":"8003_CR92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0714.2000.290301.x","volume":"29","author":"AM Pedersen","year":"2000","unstructured":"Pedersen AM, Dissing S, Fahrenkrug J, Hannibal J, Reibel J, Nauntofte B (2000) Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjogren\u2019s syndrome (pSS). J Oral Pathol Med 29:97\u2013109","journal-title":"J Oral Pathol Med"},{"key":"8003_CR93","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2249.2001.01526.x","volume":"124","author":"LJ Dawson","year":"2001","unstructured":"Dawson LJ, Field EA, Harmer AR, Smith PM (2001) Acetylcholine-evoked calcium mobilization and ion channel activation in human labial gland acinar cells from patients with primary Sjogren\u2019s syndrome. Clin Exp Immunol 124:480\u2013485","journal-title":"Clin Exp Immunol"},{"key":"8003_CR94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-3083.1999.00490.x","volume":"49","author":"MG Humphreys-Beher","year":"1999","unstructured":"Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R (1999) An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 49:7\u201310","journal-title":"Scand J Immunol"},{"key":"8003_CR95","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/10454411960070020301","volume":"7","author":"PC Fox","year":"1996","unstructured":"Fox PC, Speight PM (1996) Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjogren\u2019s syndrome. Crit Rev Oral Biol Med 7:144\u2013158","journal-title":"Crit Rev Oral Biol Med"},{"key":"8003_CR96","first-page":"2406","volume":"30","author":"J Walker","year":"2003","unstructured":"Walker J, Gordon T, Lester S, Downie-Doyle S, McEvoy D, Pile K, Waterman S, Rischmueller M (2003) Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjogren\u2019s syndrome. J Rheumatol 30:2406\u20132412","journal-title":"J Rheumatol"},{"key":"8003_CR97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9343(03)00257-2","volume":"115","author":"M Leppilahti","year":"2003","unstructured":"Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K, Auvinen A (2003) Interstitial cystitis-like urinary symptoms among patients with Sjogren\u2019s syndrome: a population-based study in Finland. Am J Med 115:62\u201365","journal-title":"Am J Med"},{"key":"8003_CR98","first-page":"147","volume":"19","author":"A Rosztoczy","year":"2001","unstructured":"Rosztoczy A, Kovacs L, Wittmann T, Lonovics J, Pokorny G (2001) Manometric assessment of impaired esophageal motor function in primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 19:147\u2013152","journal-title":"Clin Exp Rheumatol"},{"key":"8003_CR99","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.59.1.48","volume":"59","author":"L Kovacs","year":"2000","unstructured":"Kovacs L, Torok T, Bari F, Keri Z, Kovacs A, Makula E, Pokorny G (2000) Impaired microvascular response to cholinergic stimuli in primary Sjogren\u2019s syndrome. Ann Rheum Dis 59:48\u201353","journal-title":"Ann Rheum Dis"},{"key":"8003_CR100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0002-9394(14)71084-0","volume":"123","author":"C Bachmeyer","year":"1997","unstructured":"Bachmeyer C, Zuber M, Dupont S, Blanche P, Dhote R, Mas JL (1997) Adie syndrome as the initial sign of primary Sjogren syndrome. Am J Ophthalmol 123:691\u2013692","journal-title":"Am J Ophthalmol"},{"key":"8003_CR101","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/PL00011180","volume":"19","author":"B Tumiati","year":"2000","unstructured":"Tumiati B, Perazzoli F, Negro A, Pantaleoni M, Regolisti G (2000) Heart rate variability in patients with Sjogren\u2019s syndrome. Clin Rheumatol 19:477\u2013480","journal-title":"Clin Rheumatol"},{"key":"8003_CR102","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM (1996) Primary biliary cirrhosis. N Engl J Med 335:1570\u20131580","journal-title":"N Engl J Med"},{"key":"8003_CR103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","volume":"120","author":"AJ Czaja","year":"2001","unstructured":"Czaja AJ, Homburger HA (2001) Autoantibodies in liver disease. Gastroenterology 120:239\u2013249","journal-title":"Gastroenterology"},{"key":"8003_CR104","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/rheumatology\/33.8.745","volume":"33","author":"FN Skopouli","year":"1994","unstructured":"Skopouli FN, Barbatis C, Moutsopoulos HM (1994) Liver involvement in primary Sjogren\u2019s syndrome. Br J Rheumatol 33:745\u2013748","journal-title":"Br J Rheumatol"},{"key":"8003_CR105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-3083.2002.01165.x","volume":"56","author":"A Csepregi","year":"2002","unstructured":"Csepregi A, Szodoray P, Zeher M (2002) Do autoantibodies predict autoimmune liver disease in primary Sjogren\u2019s syndrome? Data of 180 patients upon a 5 year follow-up. Scand J Immunol 56:623\u2013629","journal-title":"Scand J Immunol"},{"key":"8003_CR106","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","volume":"17","author":"E Waaler","year":"1940","unstructured":"Waaler E (1940) On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 17:172\u2013188","journal-title":"Acta Pathol Microbiol Scand"},{"key":"8003_CR107","first-page":"448","volume":"63","author":"RM Pike","year":"1949","unstructured":"Pike RM, Sulkin SE, Coggeshall HC (1949) Serological reactions in rheumatoid arthritis. II. Concerning the nature of the factor in rheumatoid arthritis serum responsible for increased agglutination of sensitized sheep erythrocytes. J Immunol 63:448\u2013463","journal-title":"J Immunol"},{"key":"8003_CR108","first-page":"2034","volume":"29","author":"MM Newkirk","year":"2002","unstructured":"Newkirk MM (2002) Rheumatoid factors: what do they tell us? J Rheumatol 29:2034\u20132040","journal-title":"J Rheumatol"},{"key":"8003_CR109","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI115174","volume":"87","author":"KD Victor","year":"1991","unstructured":"Victor KD, Randen I, Thompson K, Forre O, Natvig JB, Fu SM, Capra JD (1991) Rheumatoid factors isolated from patients with autoimmune disorders are derived from germline genes distinct from those encoding the Wa, Po, and Bla cross-reactive idiotypes. J Clin Invest 87:1603\u20131613","journal-title":"J Clin Invest"},{"key":"8003_CR110","first-page":"648","volume":"66","author":"DN Hogben","year":"1986","unstructured":"Hogben DN, Devey ME (1986) Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice. Clin Exp Immunol 66:648\u2013653","journal-title":"Clin Exp Immunol"},{"key":"8003_CR111","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/art.1780340804","volume":"34","author":"F Wolfe","year":"1991","unstructured":"Wolfe F, Cathey MA, Roberts FK (1991) The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients. Arthritis Rheum 34:951\u2013960","journal-title":"Arthritis Rheum"},{"key":"8003_CR112","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","volume":"60","author":"M Pertovaara","year":"2001","unstructured":"Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A (2001) A longitudinal cohort study of Finnish patients with primary Sjogren\u2019s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 60:467\u2013472","journal-title":"Ann Rheum Dis"},{"key":"8003_CR113","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren\u2019s syndrome. Arthritis Rheum 46:741\u2013747","journal-title":"Arthritis Rheum"},{"key":"8003_CR114","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57:775\u2013788","journal-title":"Am J Med"},{"key":"8003_CR115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/01.bor.0000198002.42826.c2","volume":"18","author":"C Ferri","year":"2006","unstructured":"Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18:54\u201363","journal-title":"Curr Opin Rheumatol"},{"key":"8003_CR116","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-2362.2001.00824.x","volume":"31","author":"F Dammacco","year":"2001","unstructured":"Dammacco F, Sansonno D, Piccoli C, Tucci FA, Racanelli V (2001) The cryoglobulins: an overview. Eur J Clin Invest 31:628\u2013638","journal-title":"Eur J Clin Invest"},{"key":"8003_CR117","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2169\/internalmedicine.39.457","volume":"39","author":"T Ohara","year":"2000","unstructured":"Ohara T, Itoh Y, Itoh K (2000) Reevaluation of laboratory parameters in relation to histological findings in primary and secondary Sjogren\u2019s syndrome. Intern Med 39:457\u2013463","journal-title":"Intern Med"},{"key":"8003_CR118","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJM197811302992204","volume":"299","author":"J Zulman","year":"1978","unstructured":"Zulman J, Jaffe R, Talal N (1978) Evidence that the malignant lymphoma of Sjogren\u2019s syndrome is a monoclonal B-cell neoplasm. N Engl J Med 299:1215\u20131220","journal-title":"N Engl J Med"},{"key":"8003_CR119","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000) Clinical evolution, and morbidity and mortality of primary Sjogren\u2019s syndrome. Semin Arthritis Rheum 29:296\u2013304","journal-title":"Semin Arthritis Rheum"},{"key":"8003_CR120","first-page":"1098","volume":"29","author":"PD Katsikis","year":"1990","unstructured":"Katsikis PD, Youinou PY, Galonopoulou V, Papadopoulos NM, Tzioufas AG, Moutsopoulos HM (1990) Monoclonal process in primary Sjogren\u2019s syndrome and cross-reactive idiotype associated with rheumatoid factor. Clin Exp Immunol 82:509\u2013514","journal-title":"Arthritis Rheum"},{"key":"8003_CR121","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/1529-0131(200004)43:4<908::AID-ANR24>3.0.CO;2-K","volume":"43","author":"T Martin","year":"2000","unstructured":"Martin T, Weber JC, Levallois H, Labouret N, Soley A, Koenig S, Korganow AS, Pasquali JL (2000) Salivary gland lymphomas in patients with Sjogren\u2019s syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum 43:908\u2013916","journal-title":"Arthritis Rheum"},{"key":"8003_CR122","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.60.11.1007","volume":"60","author":"X Mariette","year":"2001","unstructured":"Mariette X (2001) Lymphomas complicating Sjogren\u2019s syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 60:1007\u20131010","journal-title":"Ann Rheum Dis"},{"key":"8003_CR123","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","volume":"39","author":"AG Tzioufas","year":"1996","unstructured":"Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM (1996) Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren\u2019s syndrome. Arthritis Rheum 39:767\u2013772","journal-title":"Arthritis Rheum"},{"key":"8003_CR124","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1091\/mbc.9.1.47","volume":"9","author":"D Zhou","year":"1998","unstructured":"Zhou D, Ursitti JA, Bloch RJ (1998) Developmental expression of spectrins in rat skeletal muscle. Mol Biol Cell 9:47\u201361","journal-title":"Mol Biol Cell"},{"key":"8003_CR125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1152\/physrev.1990.70.4.1029","volume":"70","author":"V Bennett","year":"1990","unstructured":"Bennett V (1990) Spectrin-based membrane skeleton: a multipotential adaptor between plasma membrane and cytoplasm. Physiol Rev 70:1029\u20131065","journal-title":"Physiol Rev"},{"key":"8003_CR126","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/315589a0","volume":"315","author":"D Perrin","year":"1985","unstructured":"Perrin D, Aunis D (1985) Reorganization of alpha-fodrin induced by stimulation in secretory cells. Nature 315:589\u2013592","journal-title":"Nature"},{"key":"8003_CR127","doi-asserted-by":"crossref","first-page":"24164","DOI":"10.1074\/jbc.271.39.24164","volume":"271","author":"S Lukowski","year":"1996","unstructured":"Lukowski S, Lecomte MC, Mira JP, Marin P, Gautero H, Russo-Marie F, Geny B (1996) Inhibition of phospholipase D activity by fodrin. An active role for the cytoskeleton. J Biol Chem 271:24164\u201324171","journal-title":"J Biol Chem"},{"key":"8003_CR128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/326498a0","volume":"326","author":"D Perrin","year":"1987","unstructured":"Perrin D, Langley OK, Aunis D (1987) Anti-alpha-fodrin inhibits secretion from permeabilized chromaffin cells. Nature 326:498\u2013501","journal-title":"Nature"},{"key":"8003_CR129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/313225a0","volume":"313","author":"R Siman","year":"1985","unstructured":"Siman R, Baudry M, Lynch G (1985) Regulation of glutamate receptor binding by the cytoskeletal protein fodrin. Nature 313:225\u2013228","journal-title":"Nature"},{"key":"8003_CR130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.276.5312.604","volume":"276","author":"N Haneji","year":"1997","unstructured":"Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of alphafodrin as a candidate autoantigen in primary Sjogren\u2019s syndrome. Science 276:604\u2013607","journal-title":"Science"},{"key":"8003_CR131","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/archderm.135.5.535","volume":"135","author":"T Watanabe","year":"1999","unstructured":"Watanabe T, Tsuchida T, Kanda N, Mori K, Hayashi Y, Tamaki K (1999) Anti-alpha-fodrin antibodies in Sjogren syndrome and lupus erythematosus. Arch Dermatol 135:535\u2013539","journal-title":"Arch Dermatol"},{"key":"8003_CR132","first-page":"2617","volume":"27","author":"T Witte","year":"2000","unstructured":"Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kalden JR, Lakomek HJ, Schmidt RE (2000) IgA and IgG autoantibodies against alpha-fodrin as markers for Sjogren\u2019s syndrome. Systemic lupus erythematosus. J Rheumatol 27:2617\u20132620","journal-title":"J Rheumatol"},{"key":"8003_CR133","first-page":"49","volume":"21","author":"G Nordmark","year":"2003","unstructured":"Nordmark G, Rorsman F, Ronnblom L, Cajander S, Taussig MJ, Kampe O, Winqvist O (2003) Autoantibodies to alpha-fodrin in primary Sjogren\u2019s syndrome and SLE detected by an in vitro transcription and translation assay. Clin Exp Rheumatol 21:49\u201356","journal-title":"Clin Exp Rheumatol"},{"key":"8003_CR134","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1196\/annals.1313.022","volume":"1050","author":"JL Ruiz-Tiscar","year":"2005","unstructured":"Ruiz-Tiscar JL, Lopez-Longo FJ, Sanchez-Ramon S, Santamaria B, Urrea R, Carreno L, Estecha A, Vigil D, Fernandez-Cruz E, Rodriguez-Mahou M (2005) Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren\u2019s syndrome. Ann N Y Acad Sci 1050:210\u2013216","journal-title":"Ann N Y Acad Sci"},{"key":"8003_CR135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1568-9972(03)00002-8","volume":"2","author":"KU Ulbricht","year":"2003","unstructured":"Ulbricht KU, Schmidt RE, Witte T (2003) Antibodies against alpha-fodrin in Sjogren\u2019s syndrome. Autoimmun Rev 2:109\u2013113","journal-title":"Autoimmun Rev"},{"key":"8003_CR136","first-page":"504","volume":"31","author":"A Ruffatti","year":"2004","unstructured":"Ruffatti A, Ostuni P, Grypiotis P, Botsios C, Tonello M, Grava C, Favaro M, Todesco S (2004) Sensitivity and specificity for primary Sjogren\u2019s syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA. J Rheumatol 31:504\u2013507","journal-title":"J Rheumatol"},{"key":"8003_CR137","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00296-005-0607-9","volume":"26","author":"N Turkcapar","year":"2006","unstructured":"Turkcapar N, Olmez U, Tutkak H, Duman M (2006) The importance of alpha-fodrin antibodies in the diagnosis of Sjogren\u2019s syndrome. Rheumatol Int 26:354\u2013359","journal-title":"Rheumatol Int"},{"key":"8003_CR138","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar1021","volume":"6","author":"MM Zandbelt","year":"2004","unstructured":"Zandbelt MM, Vogelzangs J, Van De Putte LB, Van Venrooij WJ, Van Den Hoogen FH (2004) Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjogren\u2019s syndrome. Arthritis Res Ther 6:R33\u2013R38","journal-title":"Arthritis Res Ther"},{"key":"8003_CR139","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.4049\/jimmunol.167.9.5449","volume":"167","author":"M Kuwana","year":"2001","unstructured":"Kuwana M, Okano T, Ogawa Y, Kaburaki J, Kawakami Y (2001) Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjogren\u2019s syndrome. J Immunol 167:5449\u20135456","journal-title":"J Immunol"},{"key":"8003_CR140","doi-asserted-by":"crossref","first-page":"31075","DOI":"10.1074\/jbc.271.49.31075","volume":"271","author":"DM Vanags","year":"1996","unstructured":"Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, Orrenius S (1996) Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 271:31075\u201331085","journal-title":"J Biol Chem"},{"key":"8003_CR141","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4049\/jimmunol.169.2.1050","volume":"169","author":"K Saegusa","year":"2002","unstructured":"Saegusa K, Ishimaru N, Yanagi K, Mishima K, Arakaki R, Suda T, Saito I, Hayashi Y (2002) Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjogren\u2019s syndrome. J Immunol 169:1050\u20131057","journal-title":"J Immunol"},{"key":"8003_CR142","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.archoralbio.2005.11.008","volume":"51","author":"Y Wang","year":"2006","unstructured":"Wang Y, Virji AS, Howard P, Sayani Y, Zhang J, Achu P, McArthur C (2006) Detection of cleaved alpha-fodrin autoantigen in Sjogren\u2019s syndrome: apoptosis and co-localisation of cleaved alphafodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands. Arch Oral Biol 51:558\u2013566","journal-title":"Arch Oral Biol"},{"key":"8003_CR143","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(02)11144-5","volume":"360","author":"S Winer","year":"2002","unstructured":"Winer S, Astsaturov I, Cheung R, Tsui H, Song A, Gaedigk R, Winer D, Sampson A, McKerlie C, Bookman A, Dosch HM (2002) Primary Sjogren\u2019s syndrome and deficiency of ICA69. Lancet 360:1063\u20131069","journal-title":"Lancet"},{"key":"8003_CR144","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1111\/j.1742-4658.2005.04864.x","volume":"272","author":"A Burkle","year":"2005","unstructured":"Burkle A (2005) Poly(ADP-ribose). The most elaborate metabolite of NAD+. Febs J 272:4576\u20134589","journal-title":"Febs J"},{"key":"8003_CR145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/bies.950130905","volume":"13","author":"G Murcia de","year":"1991","unstructured":"de Murcia G, Menissier-de Murcia J, Schreiber V (1991) Poly(ADP-ribose) polymerase: molecular biological aspects. Bioessays 13:455\u2013462","journal-title":"Bioessays"},{"key":"8003_CR146","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0968-0004(94)90280-1","volume":"19","author":"G Murcia de","year":"1994","unstructured":"de Murcia G, Menissier-de Murcia J (1994) Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 19:172\u2013176","journal-title":"Trends Biochem Sci"},{"key":"8003_CR147","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1172\/JCI113856","volume":"83","author":"H Yamanaka","year":"1989","unstructured":"Yamanaka H, Willis EH, Carson DA (1989) Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase recognize cross-reactive epitopes associated with the catalytic site of the enzyme. J Clin Invest 83:180\u2013186","journal-title":"J Clin Invest"},{"key":"8003_CR148","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1172\/JCI113150","volume":"80","author":"H Yamanaka","year":"1987","unstructured":"Yamanaka H, Willis EH, Penning CA, Peebles CL, Tan EM, Carson DA (1987) Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase. J Clin Invest 80:900\u2013904","journal-title":"J Clin Invest"},{"key":"8003_CR149","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08916939009041040","volume":"6","author":"C Negri","year":"1990","unstructured":"Negri C, Scovassi AI, Cerino A, Negroni M, Borzi RM, Meliconi R, Facchini A, Montecucco CM, Astaldi Ricotti GC (1990) Autoantibodies to poly(ADP-ribose)polymerase in autoimmune diseases. Autoimmunity 6:203\u2013209","journal-title":"Autoimmunity"},{"key":"8003_CR150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/clin.1994.1187","volume":"73","author":"S Muller","year":"1994","unstructured":"Muller S, Briand JP, Barakat S, Lagueux J, Poirier GG, de Murcia G, Isenberg DA (1994) Autoantibodies reacting with poly(ADP-ribose) and with a zinc-finger functional domain of poly(ADP-ribose) polymerase involved in the recognition of damaged DNA. Clin Immunol Immunopathol 73:187\u2013196","journal-title":"Clin Immunol Immunopathol"},{"key":"8003_CR151","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/rheumatology\/41.3.338","volume":"41","author":"F Jimenez","year":"2002","unstructured":"Jimenez F, Aiba-Masago S, Al Hashimi I, Vela-Roch N, Fernandes G, Yeh CK, Talal N, Dang H (2002) Activated caspase 3 and cleaved poly(ADP-ribose)polymerase in salivary epithelium suggest a pathogenetic mechanism for Sjogren\u2019s syndrome. Rheumatology (Oxford) 41:338\u2013342","journal-title":"Rheumatology (Oxford)"},{"key":"8003_CR152","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/art.1780270708","volume":"27","author":"CM Price","year":"1984","unstructured":"Price CM, McCarty GA, Pettijohn DE (1984) NuMA protein is a human autoantigen. Arthritis Rheum 27:774\u2013779","journal-title":"Arthritis Rheum"},{"key":"8003_CR153","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.1780391006","volume":"39","author":"LE Andrade","year":"1996","unstructured":"Andrade LE, Chan EK, Peebles CL, Tan EM (1996) Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum 39:1643\u20131653","journal-title":"Arthritis Rheum"},{"key":"8003_CR154","first-page":"232","volume":"54","author":"P Grypiotis","year":"2002","unstructured":"Grypiotis P, Ruffatti A, Tonello M, Winzler C, Radu C, Zampieri S, Favaro M, Calligaro A, Todesco S (2002) Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. Reumatismo 54:232\u2013237","journal-title":"Reumatismo"},{"key":"8003_CR155","first-page":"579","volume":"49","author":"JL Rodriguez","year":"1982","unstructured":"Rodriguez JL, Gelpi C, Thomson TM, Real FJ, Fernandez J (1982) Anti-golgi complex autoantibodies in a patient with Sjogren syndrome and lymphoma. Clin Exp Immunol 49:579\u2013586","journal-title":"Clin Exp Immunol"},{"key":"8003_CR156","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar1035","volume":"6","author":"K Nozawa","year":"2004","unstructured":"Nozawa K, Fritzler MJ, von Muhlen CA, Chan EK (2004) Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res Ther 6:R95\u2013R102","journal-title":"Arthritis Res Ther"},{"key":"8003_CR157","first-page":"1","volume":"1","author":"EKL Chan","year":"1998","unstructured":"Chan EKL, Fritzler MJ (1998) Golgins: coiled-coil proteins associated with the Golgi complex. Electronic J Biotechnol 1:1\u201310","journal-title":"Electronic J Biotechnol"},{"key":"8003_CR158","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.1780400920","volume":"40","author":"KJ Griffith","year":"1997","unstructured":"Griffith KJ, Chan EK, Lung CC, Hamel JC, Guo X, Miyachi K, Fritzler MJ (1997) Molecular cloning of a novel 97-kd Golgi complex autoantigen associated with Sjogren\u2019s syndrome. Arthritis Rheum 40:1693\u20131702","journal-title":"Arthritis Rheum"},{"key":"8003_CR159","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.1780390808","volume":"39","author":"T Fujii","year":"1996","unstructured":"Fujii T, Mimori T, Akizuki M (1996) Detection of autoantibodies to nucleolar transcription factor NOR 90\/hUBF in sera of patients with rheumatic diseases, by recombinant autoantigenbased assays. Arthritis Rheum 39:1313\u20131318","journal-title":"Arthritis Rheum"},{"key":"8003_CR160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","volume":"24","author":"CA Muhlen von","year":"1995","unstructured":"von Muhlen CA, Tan EM (1995) Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24:323\u2013358","journal-title":"Semin Arthritis Rheum"},{"key":"8003_CR161","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00997157","volume":"19","author":"H Imai","year":"1994","unstructured":"Imai H, Fritzler MJ, Neri R, Bombardieri S, Tan EM, Chan EK (1994) Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90\/hUBF autoantigens. Mol Biol Rep 19:115\u2013124","journal-title":"Mol Biol Rep"},{"key":"8003_CR162","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2005.09.021","volume":"25","author":"R Navone","year":"2005","unstructured":"Navone R, Lunardi C, Gerli R, Tinazzi E, Peterlana D, Bason C, Corrocher R, Puccetti A (2005) Identification of tear lipocalin as a novel autoantigen target in Sjogren\u2019s syndrome. J Autoimmun 25:229\u2013234","journal-title":"J Autoimmun"},{"key":"8003_CR163","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/bjo.82.4.453","volume":"82","author":"AM Gachon","year":"1998","unstructured":"Gachon AM, Lacazette E (1998) Tear lipocalin and the eye\u2019s front line of defence. Br J Ophthalmol 82:453\u2013455","journal-title":"Br J Ophthalmol"},{"key":"8003_CR164","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-4838(00)00142-4","volume":"1482","author":"B Redl","year":"2000","unstructured":"Redl B (2000) Human tear lipocalin. Biochim Biophys Acta 1482:241\u2013248","journal-title":"Biochim Biophys Acta"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8003-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-8003-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8003-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:26:38Z","timestamp":1737437198000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-8003-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,26]]},"references-count":164,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,11,8]]}},"alternative-id":["8003"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8003-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,26]]}}}